MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A new psychosocial intervention for people with Parkinsonian dementias: Adherence, barriers and facilitators

S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)

Meeting: 2017 International Congress

Abstract Number: 978

Keywords: Dementia with Lewy bodies (DLB), Interventions

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To investigate participant adherence and engagement to a home-based, companion-guided cognitive stimulation therapy adapted for people with Parkinsonian dementias (CST-PD).

Background: Adherence to rehabilitation programmes can be challenging. Over half of people with long-term conditions do not successfully adhere to recommended treatments. To foster adherence and engagement with a new home-based psychosocial therapy for Parkinson’s disease dementia (PDD) or dementia with Lewy bodies DLB), we specifically designed the therapy to be flexible, adaptable and of low intensity compatible with lifestyles and limitations of the therapy participants.

Methods: Using participant feedback diaries, we assessed therapy adherence, engagement and reach in people with PDD or DLB and their study companions recruited to the intervention arm of an ongoing single blind pilot trial of the feasibility and effectiveness of CST-PD. Companions received training to deliver the protocol-guided therapy and were asked to complete 3 x 30 minute therapy sessions with the affected participant each week. Measures included frequency of use, duration of each session and satisfaction with the therapy.  A post-therapy interview explored barriers and facilitators to implementing the therapy in the recommended way.

Results: Interim analysis of participants who have completed the therapy intervention found that 54% of the recommended number of sessions were completed with a mean of 1.8 (SD 0.8) sessions each week, which falls short of the recommended dose. 63% (563.0 minutes) of the recommended total session duration (900 minutes) was completed with a mean of 34.0 (SD 5.0) minutes/session. Not all participants completed therapy each week, however, the dose was exceeded in sessions that were completed. Barriers to adherence included: ill health, availability of companion, and competing commitments, although participants appreciated the flexibility of the intervention and the opportunity to involve other family members and friends. The relation of duration and frequency of use to indices of outcome are being explored.

Conclusions: The complex needs of the person with Parkinsonian dementia and their companion challenges adherence and may compromise therapy reach and, ultimately, efficacy. This suggests the need for flexibility and extra support during implementation.

To cite this abstract in AMA style:

S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi. A new psychosocial intervention for people with Parkinsonian dementias: Adherence, barriers and facilitators [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/a-new-psychosocial-intervention-for-people-with-parkinsonian-dementias-adherence-barriers-and-facilitators/. Accessed May 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-new-psychosocial-intervention-for-people-with-parkinsonian-dementias-adherence-barriers-and-facilitators/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley